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ABSTRACT 
Feasibility of the Use of Capillary Electrophoresis for the Study of VLDL Assembly 
 
 Intermediates. (May 2005) 
 
Elizabeth Anne White, B.S., University of Arizona 
 
Chair of Advisory Committee:  Dr. Rosemary Walzem 
 
 
 
The chicken has long been a model used for the study of plasma lipoproteins due 
to the ability to increase VLDL production by administration of estrogen.  In this study 
we were able to demonstrate successful isolation of VLDL assembly intermediates from 
the livers of hens, roosters, and estrogen treated rosters.  Particle diameter of first step 
particles, as determined by dynamic laser light scattering, was decreased from an 
average diameter of 31.5 nm in untreated birds, to 16.1 nm 12 hours after estrogen 
treatment.  Effects of estrogen waned after 24 hours and particle diameter of first step 
particles increased to an average of 23.9 nm.  These assembly intermediates, as well as 
plasma VLDL and VLDLy, were successfully studied using capillary electrophoresis 
(CE).  Effective mobilities of intact plasma VLDL and first step particles decreased after 
estrogen administration.  Hen VLDL showed a single uniform peak whereas rooster 
VLDL separated into distinct “subclasses”.   Delipidated VLDL, VLDLy and first step 
assembly intermediates were also successfully separated using CE. 
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CHAPTER I 
 
INTRODUCTION 
 
 
 Lipoproteins are essential to the transport of lipid and lipophilic molecules 
throughout the body.  Their structure, which consists of a triglyceride rich core 
surrounded by a phospholipid and protein coat, facilitates movement of hydrophobic 
lipids in the blood.  Lipoproteins are classified based on their density and on the location 
of their assembly.  Many decades of research have provided extensive knowledge of the 
circulating forms of lipoproteins which include chylomicrons, very low density 
lipoproteins (VLDL), intermediate density lipoproteins (IDL), low density lipoproteins 
(LDL) and high density lipoproteins (HDL).  Each of these classes of lipoproteins have 
unique density characteristics and density gradient ultracentrifugation is a commonly 
used method to study these particles [1, 2].  Other analytical techniques such as gel 
electrophoresis and capillary electrophoresis have also been used to further characterize 
these particles [3, 4].  Chickens have a unique class of lipoproteins, termed VLDLy.  
Synthesis of VLDLy is induced by estrogen [5, 6]. This unique characteristic of avian 
species has led to the use of chickens as a model for the study of triglyceride rich 
lipoproteins. 
___________ 
This thesis follows the style and format of the Journal of Lipid Research. 
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VLDL are triglyceride rich lipoproteins which are synthesized in the liver.  Up to 
this point, the process leading to the assembly and secretion of VLDL has not been well 
studied.  It has been proposed that VLDL assembly occurs in a two step process within 
the rough and smooth endoplasmic reticulum of hepatocytes [7, 8].  VLDL assembly 
intermediates have been visualized and isolated however, very little is known about the 
physical and chemical characteristics of these particles [8].  
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CHAPTER II 
 
REVIEW OF LITERATURE 
Lipoproteins 
Lipoproteins are amphiphilic particles synthesized by the liver and intestine for 
the transport of lipids and lipophilic molecules throughout the body.  The general 
structure of lipoproteins consists of a triglyceride (TG) rich core surrounded by a coat of 
protein, phospholipid and cholesterol.  This coat allows the lipophilic molecules to travel 
in the aqueous environment of the blood.  Lipoproteins are classified based on the 
density of the core and the location of their assembly.  The classes, in birds, are: 
portomicrons, very low density lipoproteins (VLDL), low density lipoproteins (LDL), 
intermediate density lipoproteins (IDL) and high density lipoproteins (HDL) [9].   
Intestinal absorption of lipids in birds is accomplished via the portal circulation 
with subsequent uptake into the liver. Dietary triglycerides and other lipophilic 
molecules are assembled into portomicrons prior to direct secretion into the portal vein 
[10].  Triglyceride within the portomicron is hydrolyzed by lipoprotein lipase as it 
travels through the circulation.  The portomicron remnant is then taken into hepatocytes 
and degraded.  Upon entry into hepatocytes remnant lipids mix with triglyceride and 
cholesterol synthesized de novo by the liver to form what is termed the endogenous lipid 
pool. The endogenous lipid pool can then be assembled into VLDL.  
After VLDL is assembled in the liver, it is then secreted into the circulation.  As 
the TG in the VLDL particle is hydrolyzed by lipoprotein lipase the particle diameter 
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decreases and transforms first into a more dense IDL.  The IDL particle can be further 
hydrolyzed to form LDL [9].  VLDL and its metabolites, IDL and LDL, are essential for 
the transport of fatty acids, cholesterol and fat-soluble vitamins throughout the body.   
Apolipoproteins are those proteins found in the lipoprotein’s outer coat.  Because 
these molecules are amphipathic they are able to associate with neutral lipids and 
phospholipids within the aqueous environment of the bloodstream.  Apolipoproteins 
contribute to the lipoprotein’s structure and stability.  Apolipoproteins also serve as 
ligands for receptors and co activators for enzymes as well as possessing independent 
catalytic and lipid transfer activity. Apolipoproteins vary in both molecular weight and 
physical properties such as isoelectric point, pI (Table 1).  Apolipoproteins are named 
using the abbreviation apo in conjunction with letter and Roman numeral combinations.   
Apolipoprotein B (apo B) and apolipoprotein A-I (apo A-I) are considered the 
primary structural apolipoproteins of triglyceride-rich (Portomicrons, VLDL, IDL and 
LDL) and HDL, respectively. While sequence variation exists, Apo B and Apo A-I are 
common to all vertebrates. Human serum lipoproteins also contain smaller 
apolipoproteins not found in all species. Examples of such apolipoproteins include apo 
A-II, apo E, apo D and the apo C proteins (-I, II and III). 
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Table 1 
Approximate molecular weight (MW) and theoretical isoelectric points (pI) of various apolipoproteins 
found in avian species.  Calculations of theoretical pI were done with ExPASy [11]. 
 
Apolipoprotein Approximate MW 
(kDa) 
Theoretical pI 
Apo B 550 6.59 
Apo A-I 28 5.26 
Apo C-I 6.6 7.93 
Apo VLDL II 9.3 9.21 
 
The major structural protein of VLDL is Apo B.  In mammals Apo B has two 
common forms, a full-length 550 kDa form termed Apo B100 and a shorter form created 
by RNA editing termed Apo B48 because it is about 48% as long as Apo B100 [12, 13]. 
Chickens do not make Apo B48 [14]. Because Apo B is amphipathic, it has hydrophilic 
regions that interact with polar surface lipids, as well as many hydrophobic regions that 
interact with core lipids.  The amphipathic nature of Apo B is essential to its function in 
maintaining lipoprotein structure and stability.  The sequence of apo B, specifically the 
lipophilic regions, is highly conserved across species [15].  Although the smaller 
apolipoproteins also have specific functions they are not necessary for the structure of 
the lipoprotein and are easily exchanged between particles. Apo B, however, is an 
integral structural protein for VLDL, IDL and LDL.   
Apolipoprotein A-I is the defining structural protein for HDL, however, 
“assembly” of this particle occurs in peripheral tissues. The non-structural function of 
apo A-I is to activate lecithin-cholesterol acyltransferase (LCAT) [16].  LCAT is 
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necessary for the esterification of cholesterol in circulating HDL particles. Due to LCAT 
activity, HDL particles are said to mature, as synthesized cholesterol ester locates in the 
particle’s core causing it to increase in diameter.  Apolipoproteins similar to the Apo Cs 
have been found in avian species.  Apo C-II is an activator of lipoprotein lipase and a 
similar protein is found on the VLDL of chickens [17].   
VLDLy 
Distinctive differences are found in VLDLy as compared to VLDL.  These 
differences develop in response to elevations in plasma estrogen in the laying hen.  Both 
physical and chemical changes occur in hepatic VLDL assembly processes in order to 
form VLDLy, whose metabolic fate differs from VLDL.  VLDLy are resistant to 
hydrolysis by lipoprotein lipase and this facilitates deposition of TG into the developing 
egg yolk [18, 19].  The average diameter of VLDLy is decreased from the typical 60 nm 
of nonlaying hens, to 30 nm in a laying hen (Figure 1) [20].   The VLDLy particles are 
also more uniform in diameter than are generic VLDL.   
The physical and chemical properties of VLDLy are essential to its function.  
Egg yolk must provide all of the energy requirements for the developing embryo.  Most 
of the egg yolk is composed of TG in the form of VLDLy.  Circulating VLDL must be 
able to support the high demand for TG during egg laying.  A hen’s ovary has thousands 
of oocytes [21].  At any one time only a few of these oocytes accumulate TG and 
developing into mature ova.  Several layers of tissue separate the circulating VLDLy 
from the developing oocytes [21].  Approximately 5g of VLDLy-TG must be transferred 
from the circulation into the developing follicles each day [22].   
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Fig. 1.  Particle size distribution of plasma VLDL from adult roosters (stippled bars) and adult egg-laying 
hens (solid bars).  Particle size determined by dynamic laser light scattering.  Figure used with permission 
from the American Society of Nutritional Sciences: Walzem, R.L. Estrogen Induction of VLDLy assembly 
in egg-laying hens. Journal of Nutrition, 129: 67s-472s [6].   
 
Decreased particle diameter is essential for yolk deposition as the follicle is size 
selective.  Using electron microscopy, Perry et al. concluded that only lipoproteins 
below 52 nm in diameter are able to pass through the various layers of connective and 
steroidogenic tissues that comprise the follicle wall.  For this reason lipoproteins of 
intestinal origin, portomicrons which are generally much larger in diameter, are excluded 
from the yolk [22].  Although particle diameter is the primary determinant, there is also a 
difference in charge between the apolipoproteins and the proteins of the basal lamina 
which may contribute to the movement of VLDL across this membrane [22]. 
Lipase resistance is also necessary for the function of VLDLy.  If lipoprotein 
lipase were to act on VLDLy it would become depleted of TG.  As a result TG-deficient 
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yolk would form which would be unable to meet the energy requirements of the 
incubating embryo [19].  Apo VLDL II is responsible for the lipase resistance of the 
VLDLy particle [23]. 
Egg yolk deposition occurs by receptor-mediated endocytosis.  Both apo B and 
apo VLDL II are integral VLDLy apolipoproteins, that is, neither are exchanged 
between particles.  Early on it was thought that role of VLDL II was to serve as the 
ligand for these receptors.  However, Nimpf et al. demonstrated that VLDL II is not the 
ligand [24], and it was later discovered that Apo B is the receptor ligand [25]. Although 
apo VLDL II is not required for endocytosis of VLDLy it is still essential for egg yolk 
deposition as the presence of apo VLDL II inhibits the action of lipoprotein lipase on 
VLDLy [23].  As apo VLDL II only appears after estrogen induction it is also possible 
that this protein leads to the decreased initial diameter of the VLDLy particles. 
In addition to changes in the physical and functional properties of VLDL, 
estrogen induces an overall increase in the production apo B-containing lipoproteins in 
the form of VLDLy.  Upregulation of VLDL synthesis can be induced in immature hens 
or roosters through the injection of exogenous estrogen [5].   As would be expected with 
such an increase in plasma VLDL there is a subsequent increase in total plasma TG [26]. 
This massive upregulation in VLDL synthesis provides an opportune setting to study the 
processes involved in the assembly and secretion of VLDL particles. 
Effects of Estrogen on the Liver 
The presence of estrogen directly stimulates the production of unique proteins: 
the vitellogenins and apo VLDL II, all of which play an important role in egg yolk 
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deposition.  Apo VLDL II as an apolipoprotein unique to avian species.  In the chicken 
Apo VLDL II is found as a homodimer with each subunit being 9 kDa [26].  In other 
avian species, such as quail, apo VLDL II is found as a monomer.  Both the monomeric 
and dimeric forms effectively inhibit lipoprotein lipase [27].  Vitellogenins, although not 
physically associated with VLDL, also play a role in yolk formation and constitute a 
phospholipid rich very high density lipoprotein (d>1.195 g/mL) fraction in plasma [17]. 
Estrogen effectively increases synthesis of apo VLDL II by several mechanisms.  
First, estrogen directly induces transcription of apo VLDL II mRNA [28].  The presence 
of estrogen also increases the stability of apo VLDL II mRNA.  This occurs by inducing 
the formation of a poly-adenosine tail which increases the half life of the mRNA [29].  
The increased stability leads to an accumulation of VLDL II mRNA.  For this reason 
VLDL II, and subsequently VLDLy, continue to be produced for an extended period of 
time, approximately 24 hours, after a single exposure to estrogen [5]. 
Assembly of VLDL 
Although many individual events are required, the assembly of VLDL is 
proposed to occur in two broad steps.  A series of physical observations led to this 
proposed mechanism.  In 1976, Alexander et al. observed that within the rough 
endoplasmic reticulum (RER) there were regions that were richly immunopositive for 
apo B.  However, the RER did not contain any particles matching the diameter criteria 
for VLDL.  It was also noticed that there were regions of the smooth endoplasmic 
reticulum (SER) that contained large lipid filled particles of VLDL diameter that were 
not immunoreactive for apo B [8].  Based on these observations Alexander et al. 
  10   
concluded that there were two separate VLDL assembly intermediates.  The first of 
which being a small apo B containing particle, found in the RER.  The second being a 
large lipid filled particle found in the SER which did not contain apo B. 
Microsomal triglyceride transfer protein (MTP) is essential for the lipidation of 
apo B containing lipoproteins.  MTP is a heterodimer consisting of subunits of 55kDa 
and 97 kDa.  The smaller of these two subunits is an enzyme, protein disulphide 
isomerase.  The larger subunit is unique to MTP.  MTP is found exclusively within 
microsomes isolated from the liver and intestines [30].  MTP acts to shuttle lipid from 
the ER membrane to developing VLDL assembly intermediates.   It has been shown that 
MTP preferentially transports hydrophobic lipid molecules namely TG and cholesterol 
esters, although it can transport more polar lipids as well [31]. 
The first step of VLDL assembly and secretion involves the synthesis of a small 
lipid-poor apo B-100 containing particle.  In this first step lipid is added to apo B 
cotranslationally.   As apo B is contranslationally translocated into the RER lumen, lipid 
is transferred by MTP and added into the core of the growing first step particle [30, 32].  
Although apo B is lipidated contranslationally the bulk of the lipid is added during the 
second step.   
The second step of VLDL assembly involves the synthesis of a large apo B-free, 
TG rich particle.  These TG rich particles are thought to be synthesized within the 
smooth endoplasmic reticulum (SER) [8].  Formation of these TG rich particles is also 
dependent on MTP [30, 33]. These two particles, the small apo B containing first step 
particle and the large apo B free lipid droplet, somehow join to form the mature VLDL 
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[34-36]. Unlike formation of the two VLDL precursors, this final step in VLDL 
assembly is not MTP dependent; however the precise mediators involved in the final 
merging of the two VLDL precursors are unknown. Recently, Gilham et al.. proposed 
that particle fusion per se may not be involved and that TG-hydrolysis coupled to 
diacylglycerol acyl transferase (DGAT) activity may drive the process [37]. It is thought 
that the juncture of the RER and SER is where the two VLDL precursor particles join.  
Completion of particle remodeling to form mature VLDL occurs within the Golgi 
apparatus, prior to secretion into the Space of Disse. 
 Figure 2 provides a schematic for the proposed two step theory of VLDL 
assembly.  The first event in step one involves the translation and concurrent tertiary 
folding, of apo B.  As the protein folds a lipid binding cavity is created.  During the 
second event of step one, MTP begins to deposit a small amount of triglyceride into the 
lipophilic cavity of apo B.  Events 3 and 4 further depict the role of MTP in the transfer 
of lipid to the developing first step particle.  After translation of apo B is complete the 
first step particle is released from the ribosome and the particle travels down the 
secretory pathway towards the SER, event 5.  The first step particle then meets the large 
apo B free second step particle prior to formation of mature VLDL during the second 
step designated by event 6 [7].  Little information is available on the processes and 
events leading to the formation of the large apo B-free particle.   
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Fig. 2.  Schematic of the two step model of VLDL assembly.  Lipid is added to apo B cotranslationally, 
mediated by MTP.  After being released from the ribosome the first step particle travels to the junction of 
the SER.  It can then fuse with the large TG containing second step particle forming mature VLDL.  
Figure used with permission from Lippincott Williams & Wilkins: Shelness, G. Very-low-density 
lipoprotein assembly and secretion. Current Opinion in Lipidology. 12: 151-157 [7]. 
 
 
Hamilton et al. developed a method of isolating RER that has allowed further 
study of VLDL assembly intermediates.  This method involves calcium precipitation of 
the RER from whole liver homogenates [38]. Successful isolations of RER have been 
demonstrated in our laboratory with both hamsters and chickens using this or adaptations 
of this method.  After RER isolation, VLDL assembly precursor particles can be released 
by membrane rupture with NaCO3 and further isolated using density gradient 
ultracentrifugation. 
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Separation of Lipoproteins 
Classes of lipoproteins can be separated by many methods.  The most common 
method has been density gradient separation.  The key to this technique is that the 
plasma is made to be more dense than the lipoproteins.  Each lipoprotein class, VLDL, 
IDL, LDL and HDL has a characteristic density range.   The density range for each class 
varies by species.  The density distribution of lipoproteins shifts in avian species in 
response to estrogen, see Table 2. The laying hen demonstrates marked alterations in 
lipoprotein density when compared to estrogen naive birds.  Very low density 
lipoproteins were found up to densities of 1.030 g/mL, overlapping with the IDL.  
Densities of HDL and LDL also overlap.  These two lipoprotein classes were 
distinguishable based on apolipoprotein content with apo B being exclusive to LDL and 
apo AI being predominant on HDL [2, 17].  
 
Table 2 
Density profile for lipoproteins isolated from immature male chickens and laying hens which were 
separated by density gradient ultracentrifugation.  Note the overlap of density ranges in the laying hen [2, 
17].   
 
Particle Immature Male 
Density Range (g/mL) 
Particle Laying Hen 
Density Range (g/mL) 
VLDL  <1.016 VLDL/IDL <1.030 
IDL 1.016 – 1.020   
LDL 1.020 – 1.046 LDL/HDL 1.030 – 1.158 
HDL >1.086   
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Using suspending solutions of specific densities one can isolate the desired class 
of lipoproteins.  Plasma is mixed with a suspending solution that is more dense than the 
desired lipoprotein class.  After ultracentrifugation the desired lipoproteins will have 
floated to the top and can be easily collected.  Fractionation can be done sequentially 
with suspending solutions of increasing density to isolate each lipoprotein class from a 
single plasma sample [39].   
Density ultracentrifugation can be used as an analytical or a preparative 
technique.  The use of density ultracentrifugation as a preparative method has allowed 
for further study of the chemical and physical properties of individual lipoprotein 
classes.  This separation process has been integral to lipoprotein research for nearly 30 
years.  Much of the knowledge regarding lipoprotein structure and function has been 
made possible through the use of density ultracentrifugation. 
Recent ultracentrifugation studies have focused on developing methods to 
observe individual variations in lipoprotein density profiles.  Although the density 
ranges for the major classes of lipoproteins are well known there is much variability of 
lipoprotein subclasses between individuals.  Individual variations in lipoprotein density 
profiles have implications for cardiovascular risk in humans.  For example individuals 
with small dense LDL have an increased risk of developing cardiovascular disease [40].  
Stability of Lipoproteins 
 Storage of isolated lipoproteins has long proposed a problem for researchers.  
Freezing is used widely for the preservation of biological samples.  However, it was 
noted early on that the freeze-thaw process significantly alters the physical properties of 
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lipoproteins.  Although the total cholesterol and triglyceride content of previously frozen 
samples is unchanged by freezing and thawing, physical changes have been observed in 
the lipoproteins themselves [41, 42].  In 1992, Rumsey, et al., demonstrated successful 
cryopreservation of human LDL at -70°C with the addition of a 10% sucrose solution.  
Without addition of sucrose LDL particles aggregated during the freeze-thaw process.  
Those LDL frozen with sucrose remained in solution and did not aggregate.  The LDL 
particles were analyzed using several methods including spectrophotometric analysis, 
column gel filtration and electron microscopy.  Physical and chemical aspects of LDL 
frozen with 10% sucrose solution were similar to fresh samples [43, 44].  
Capillary Electrophoresis 
Capillary electrophoresis (CE) has been used to characterize and compare 
lipoproteins [3]. In general, CE separates ions based on charge density.  The driving 
principle of this type of electrophoresis is that charged species will migrate at a specific 
rate, directly related to its charge and inversely related to its size, when exposed to an 
electrical potential.  With CE, solutes migrate through a silica capillary tube exposed to 
an electrical potential gradient. The term electrophoretic migration is used to describe 
the movement of an electrolyte solution through a capillary that is exposed to an electric 
current.  Capillary flow moves from the anode, the positive terminal, towards the 
cathode, the negative terminal.  The silica-coated capillary carries a negative charge.  
When an electrolyte solution is introduced a bilayer is created by the formation of ionic 
bonds between the capillary coating and the cations of the electrolyte solution.  This 
gives the inside of the capillary a positive charge.  When a current is applied these 
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cations move towards the cathode pulling the electrolyte solution with them.  The net 
movement of the electrolyte solution is determined by the strength of the current and the 
charged surface of the inside of the capillary.  This is termed electroosmotic flow.   
Since electroosmotic flow moves towards the cathode, positively charged ions 
will migrate more quickly, moving towards the negative terminal.  Negatively charged 
particles will move more slowly.  The velocity at which any given particle moves is the 
sum of the electroosmotic flow and the electrophoretic velocity.  Electrophoretic 
velocity is proportional to the size of the ion and inversely proportional to the friction 
coefficient of the ion.  For this reason molecules of similar size will migrate according to 
charge.  Any charged species can be separated using this technique.  The characteristics 
of the molecule itself are not the only determinants for the time it takes for a given ion to 
migrate through the capillary.  Ion movement is also influenced by the length of the 
capillary, the ionic strength of the electrolyte solution and the applied voltage. 
Capillary electrophoresis, when compared to more traditional slab 
electrophoresis, provides the means to achieve higher resolution separations.  Increased 
resolution is possible because the capillary has an inner diameter of less than 100 µm 
and as a result radial diffusion is minimal.  It also allows for high speed separations with 
very small sample volumes [45, 46].  
There are many detection methods that can be used in conjunction with CE.  The 
most common method of detection is absorbance of ultraviolet (UV) light.  This type of 
detection is performed on column thereby allowing direct monitoring of individual 
separations.  In order to monitor UV absorbance a small area of the capillary’s protective 
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outer coating is removed to allow light of the desired wavelengths to pass through the 
column.  UV absorbance is measured as the ions migrate past the capillary “window”.  
This method can also be used to detect fluorescence.  A more recent advance is the use 
of mass spectrometric detection of eluting ions.  Electrospray mass spectrometry is 
commonly used and can be performed in conjunction with UV monitoring.  This method 
is of particular interest because of it’s applications to biochemistry and medicine [47, 
48]. 
Graphic representations of CE elution profiles are termed electropherograms. An 
electropherogram is a plot of time vs. detector response.  In the case of a UV detector, 
UV absorbance is plotted along the y-axis and time in minutes plotted along the x-axis.  
The effective mobility (µ e) of individual analytes is calculated based on relative 
migration of the sample compared to that of a neutral marker.  This marker is termed the 
electroosmotic flow marker (EOF).  Effective mobility is calculated as cm2/v.s using the 
following equation: 
µe =LcLd (1/t-1/tEOF) 
        V 
 
where Lc is the total length of the capillary (cm), Ld is the length of the capillary from 
injector to detector (cm), V is the applied voltage (volts), t is the migration time of the 
sample (sec), and tEOF is the migration time of the EOF marker (sec).  Effective mobility 
of the EOF is zero.  Any peak that appears before the EOF represents a cationic solute 
and has positive µe.  Peaks appearing after the EOF represent anionic solutes and have 
negative µe.  
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Electropherograms can also be used to quantify components of a sample.  This 
can be relative concentration comparing the areas under the peak(s) of interest.  Or, if a 
known standard is available, peak areas can be compared to the standard solution at a 
given concentration.  
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Fig. 3. Sample electropherogram of two compounds (A and B).   
 
Figure 3 is a sample of an electropherogram.  In this example both compounds 
appear after the EOF marker therefore they are both anionic and have negative µe. 
Compound A has a lower µe than compound B.  Analytes with larger µe elute at a later 
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time.  Large µe relates directly to larger charge density.  In this example the 
electropherograms would be interpreted as compound B having a larger µ e and therefore 
larger charge/mass than compound A.  If the two compounds were known to have 
similar charge than this would indicate that compound B is smaller than compound A.  If 
the two compounds are known to be of similar MW than this would indicate that 
compound B is more negatively charged than compound B.  As the two peaks are of 
similar intensity it can be inferred that there are similar concentrations of the two 
compounds. 
Capillary Electrophoresis of Lipoproteins 
Capillary electrophoresis has been used to characterize and compare classes of 
lipoproteins as well as for characterization of apolipoproteins.  Because lipids are 
neutral, and CE separates according to charge, lipoproteins migrate based on their charge 
density, or charge/volume ratio, which is primarily dictated by the apolipoproteins 
located in the phospholipid coat.  Cruzado et al. described the movement of human HDL 
and LDL using this technique.  Despite the larger diameter of LDL, both particles 
demonstrated approximately the same effective mobilities.  This was thought to be 
related to the presence of apo B, a large, negatively charged protein, on the surface of the 
LDL [49]. 
Lipoproteins can be broken apart into their individual components using a 
detergent.  By delipidating the lipoproteins individual apolipoproteins as well as lipids 
can be detected individually.  Although the lipids are neutral the addition of a detergent, 
such as SDS, gives a negative charge to these molecules. Delipidation techniques have 
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been used to separate, identify and quantify apolipoproteins.  Cruzado et al. 
demonstrated the use of CE in the quantification of apolipoproteins.  Using SDS as a 
detergent they successfully separated and quantified both apo A-I and A-II from human 
HDL [3].  In 1998 the same laboratory successfully characterized and quantified apo B 
using similar techniques [50]. 
UV absorbance is typically measured over a range of wavelengths for any given 
sample.  Analyzing the sample at specific wavelengths can provide information about 
the composition of the sample.  Individual amino acids absorb at different wavelengths.  
The aromatic amino acids, tyrosine, tryptophan and phenylalanine, have the highest UV 
absorbance of all amino acids, at ~280 nm.  For this reason, maximal UV absorbance of 
proteins occurs at this wavelength.  Lipids typically absorb from 200 to 214 nm, due to 
the presence of carboxyl groups which absorb UV light in this range.  When a 
lipoprotein profile is analyzed at a lower wavelength, such as 214 nm both lipid and 
protein components are detected in the sample.  When the same sample is analyzed at 
280 nm only the protein components are detected.  This difference in absorption 
properties is useful when analyzing samples which contain high concentrations of lipids, 
such as VLDL.  Analyzing these samples at 280 nm allow determination of peaks which 
represent protein components [48]. 
Many efforts to use CE in the analysis of lipoproteins are targeted at clinical 
applications, such as, creating an individual’s lipoprotein profile.  It has been used to 
separate lipoprotein classes and subclasses [51].  In vitro oxidation studies have shown 
that oxidation of LDL can be detected using CE[47].  This is of particular interest since 
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oxidation of LDL is thought to be a key event in the development of atherosclerosis [47, 
52].  
 This study sought to determine the feasibility using CE for the study of VLDL, 
VLDLy and VLDL assembly intermediates.  The use of CE would allow further 
characterization of the physical properties of these particles.  Very little is known about 
the physical characteristics of first step particles, and isolation of these intermediates is 
labor intensive.  The small sample volume required for CE makes it an appealing 
candidate method for the study of these particles.  Previous studies in our collaborators 
laboratory have demonstrated profiling of individual human lipoprotein classes, 
successful delipidation of human lipoproteins as well as characterization and 
quantitation of apolipoproteins using CE [3, 50].  Using adaptations of these methods 
this study sought to increase our knowledge of VLDL, VLDLy and first step VLDL 
assembly intermediates.  Increasing our knowledge of VLDL assembly intermediates 
will give us further insight into the VLDL assembly process. 
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CHAPTER III 
 
OBJECTIVES 
 
The first objective of this project was to demonstrate successful isolation of 
VLDL assembly intermediates from chicken liver and determine particle diameter 
distributions for these particles.  The next objective was to establish conditions that will 
allow the use of CE to characterize these particles as well as plasma VLDL and VLDLy.  
Capillary electrophoresis allows characterization of these particles based on their overall 
charge density.  If successful this would allow us to compare plasma VLDL to first step 
VLDL particles.  We will also be able to determine differences in the charge densities of 
plasma VLDL and VLDLy. Comparisons of physical properties among lipoprotein 
particles at different stages in the assembly process under physiologically different 
settings can reveal important structural information about the products of biochemical 
processes.   
We hypothesize that VLDLy particles will be more positively charged than 
VLDL particles due to the presence of a positively charged protein, VLDL II, pI 9.21.  
VLDLy also have decreased mass in comparison to VLDL.  Overall these particles 
should have a lower charge:volume and therefore lower effective mobility. 
Based on the two step theory of VLDL assembly Apo B is present on the first 
step VLDL particle.  However, it is not known whether first step VLDLy particles also 
contain other apolipoproteins such as apo VLDL II or apo A-I.  If either, or both, of 
these proteins are found on the first step particle it would affect the charge:volume.  Apo 
A-I would create a more negatively charged particle.  Again, Apo VLDL II, would 
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impart a more positive charge to the first step particle.  Because overall VLDL secretion 
increases with estrogen induction, we would expect an increase in the area under the 
peak representing the VLDLy and first step VLDLy particles when compared to VLDL 
or first step VLDL respectively when similar volumes of similarly prepared materials are 
analyzed. 
Our second objective was to attempt delipidation of plasma and first step VLDL 
and VLDLy using sodium dodecyl sulfate (SDS) and subsequent separation with CE.  If 
successful, this approach would allow us to determine the presence of the various 
apolipoproteins on each these particles initially by mobility characteristics and 
ultimately by mass spectral analyses. 
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CHAPTER IV 
METHODS AND MATERIALS 
 
Animal Protocol 
Thirty 8-week old single comb white leghorn roosters were obtained and housed 
according to an approved animal protocol (see Appendix).  Ten single comb white 
leghorn laying hens were also obtained and housed according to the same protocol.  A 
minimum of two mL of whole blood was collected from the brachial vein of each bird.  
Blood was collected via 23 gauge needle and syringe then transferred into tubes 
containing EDTA. (BD Vacutainer, Franklin Lakes, NJ) Tubes were inverted 3x and 
held on ice until plasma separation by centrifugation at 4º C, 2500 x G for 20min. 
For estrogen induction of VLDLy assembly, diethylstilbesterol (DES) dissolved 
in oil (10mg/mL) was injected subcutaneously in the inguinal skin-fold of 6 of these 
roosters at the dose of 10mg/kg-body weight.   Birds were sacrificed at 12 and 24 hours 
after DES treatment.  Three control birds and one hen were also studied; these subjects 
were injected with vehicle oil lacking DES.  
Harvest Procedure 
Birds were anesthetized by placing them in chamber filled with isoflurane and 
oxygen.  When fully anesthetized the bird was removed from the anesthesia induction 
chamber and transferred to a prepared surgical table and a face mask attached to provide 
continued sedation via continued provision of isoflurane and oxygen.  The body cavity 
was opened via central midline incision and blood samples obtained via heart puncture.  
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A minimum of 5mL of blood was collected directly into tubes containing EDTA via 20 
gauge needle (BD Vacutainer). Whole blood was held on ice until plasma separation.  
The liver was removed, weighed and held on ice for RER isolation. At this point the bird 
was exsanguinated via laceration of the heart.  
Liver Perfusion 
 To better understand the effects of estrogen on the liver of the laying hen a 
method of fixation was desired that would maintain the ultrastructure of the hepatocytes 
as much as possible.  Perfusion is a technique which uses the animal’s own vasculature 
as a route of distributing fixative throughout the body.  A method of perfusion 
previously described by Angermuller and Fahimi was used [53].  The fixative solution 
contained 1.5% glutaraldehyde (Ladd Research Industries, Williston, VT), 4% PVP, 
.05% CaCl2, in .1M Sodium Cacodylate (Ted Pella Inc., Redding CA) buffer pH 7.4.  
The samples were than examined using electron microscopy. 
Prior to perfusion birds were first injected with heparin in the dose of 10units/kg 
body weight to prevent clotting during perfusion.  Approximately 45 minutes after 
anticoagulation the bird was anesthetized and the body cavity opened as described 
above.  Again, a minimum of 5mL of blood was collected directly into tubes container 
EDTA via 20 gauge needle (BD Vacutainer) via heart puncture.  The perfusion setup 
consisted of two flasks, one containing .1M sodium cacodylate buffer and the other 
containing the fixative solution.  These were connected to another empty flask, which 
was used to maintain pressure.  Y-shaped tubing was used to attach the two buffer 
containing flasks to a 24 gauge needle.  The needle was then inserted into the heart.  The 
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valve to the cacodylate buffer was opened and pressure was raised to and maintained at 
100mm Hg using a manometer.  The buffer solution was allowed to flow through the 
bird for 2 minutes.  Following this wash the valve to the fixative solution was opened 
and the buffer valve closed.  The fixative solution was allowed to flow through the bird 
for 40 minutes.  After this time the valve was closed and the needle removed.  A small 
section of the right lobe of the liver was removed and stored in a vial containing the 
fixative solution.  These sections were sent to the laboratory of Dr. Robert Hamilton for 
analysis with electron microscopy. 
Extraction of Rough Endoplasmic Reticulum 
This method of RER extraction was adapted from the previously described 
method of Dr. Robert Hamilton [38].  The livers of the three birds at each time point 
were combined and minced finely.  Approximately 20 grams of liver from each 
combined sample was combined with 140 mM KCl added in the proportion of 18 mL 
KCl/10g liver.  The diluted membranes were further homogenized with a Polytron, PT 
3100 for 30 seconds.   
The prepared homogenate was split between two 50 mL polycarbonate centrifuge 
tubes (Nalgene), and the total volume brought to 40 mL with 140 mM KCl.  The tubes 
were then centrifuged at 8K rpm, 4°C for 10 min using a Sorvall RC5C centrifuge.  
Floating fat was aspirated and the infranatant decanted into a fresh tube while being 
careful to prevent pelleted non-RER membrane transfer.  This process was continued 
until floating fat was no longer visible or at most for 3 centrifugations. 
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Infranatants were combined and the volume measured.  They were then titrated 
with 8mM CaCl2.  The ratio of supernatant to CaCl2 was 75mL supernatant/450 mL 
CaCl2.  The titrated solution sat for at least one hour prior to centrifugation.  The solution 
was again divided into 50 mL polycarbonate centrifuge tubes and centrifuged with a 
Sorvall RC5C at 8K rpm, 4°C for 20 minutes.  Supernatant was discarded and the now 
pelleted RER membranes resuspended with 100 mM Na2CO3.  The suspended RER 
membrane pellets were further diluted to a final volume of 3.63 mL Na2CO3 /g liver 
processed. This step releases the luminal contents of the RER including VLDL precursor 
particles.  The resulting suspension was mixed vigorously every 20 minutes for 2 hours 
and then ultracentrifuged with a Beckman L8-70M centrifuge at 35K rpm, 4°C for 18 
hours. 
Following ultracentrifugation the first step particle fraction appears as a yellow 
cloud next to the pellet.  This first step particle fraction was collected and total volume 
recorded.  Sufficient desiccated KBr was added to the first step particle fraction to bring 
the solution density to 1.10 g/mL and allowed to dissolve.  A volume of 2.6 mL of this 
solution was placed into the bottom of a 6.8 mL ultracentrifuge tube and overlaid with 
1.2 g/mL NaCl/NaBr solution.  The prepared tubes were then ultracentrifuged with a 
Beckman L8-70M centrifuge at 30K rpm, 4°C for 18 hours. 
The first step particles form a band at an approximate density of 1.10 g/mL, and 
were collected with a pipette.  Diameter of first step particles was determined by 
dynamic laser light scattering [18].   First step particles were then aliquotted and frozen, 
see cryopreservation below, prior to further analysis [43].   
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Separation of Plasma Lipoproteins 
Plasma VLDL was separated by density gradient ultracentrifugation methods 
routinely used within the laboratory.  Density solutions were created by adding NaBr to 
a stock solution of NaCl of density 1.0063g/ml containing .01% EDTA and 50ku/l each 
of streptomycin and penicillin.  Five mL of density solution were layered over 1 mL of 
plasma prior to ultracentrifugation.  All samples were centrifuged at 35,000 rpm for 
18hrs.  Final density for VLDL separation was 1.02g/ml.  The top 500µl from each 
sample was collected using a narrow-bore pipette and particle diameter determined using 
dynamic laser light scattering.  Samples were analyzed immediately or aliquotted and 
frozen at -80°.  Prior to freezing stock sucrose solution was added to each sample, final 
concentration of sucrose was 10%. 
Dynamic Laser Light Scattering 
The diameter distribution of plasma VLDL and 1st step particles was determined 
by dynamic laser light scattering with a NanoTrac® 250 (Microtrac, Inc., 
Montgomeryville, PA).  In this method approximately 200µl of sample was placed into a 
polypropylene cuvette and the probe of the detector lowered into the sample.  Using 
system software the laser light was activated.  Resultant laser scattering from the 
lipoprotein particles was measured for 30 sec and repeated 3 times for each sample.  
Averages of the three measurements were calculated by system software immediately 
after each run.  This was done for each VLDL, VLDLy and first step particle sample.   
The principle of this technique is based on the Doppler light shift that occurs 
when the laser light passes through the individual lipoprotein particles which are 
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undergoing Brownian movement.  The velocity distribution of the laser scattering is a 
function of particle diameter, fluid temperature and fluid viscosity.  Fluid viscosity and 
temperature are known and therefore the resultant distribution is representative of the 
diameter of the particles.  System software is able to convert this information into a 
diameter distribution of the particles in a given sample.  This laboratory has used this 
method extensively in the study of lipoproteins of both animal and human origin.  
Previous studies in this laboratory were able to demonstrate the decreased particle 
diameter of VLDLy [18, 20]. 
Cryopreservation 
 Stock solution for cryopreservation of lipoproteins was as follows; 50% sucrose, 
150 mM NaCl, .24 mM EDTA, pH 7.4. A final concentration of 10% sucrose 
(weight/volume) was achieved by direct addition of 100 µL of the stock sucrose solution 
to 400 µL aliquots of VLDL or 1st step particles.  Samples were stored at -80°C until 
further analysis [43]. 
Preparation of Capillary Cartridge 
 Capillaries were prepared using Beckman capillary cartridges (Beckman 
Instruments, Fullerton, CA).  Approximately 60cm of untreated fused silica capillary 
with an inner diameter of 76µm and an outer diameter of 360µm (Polymicro 
Technologies, Phoenix, AZ) was measured and cut using a ceramic square.  Care was 
taken to achieve a flat end to the cut capillary.  The total length of the capillary was 
measured exactly to ± 1.0 mm.  A place 7.6 cm from one end was measured and marked 
using a fine tipped pen.  This point marks the location of the capillary window.  To form 
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the window, the capillary was inserted into a small metal coil attached to a power 
supply.  The power supply was turned on and the capillary rotated within the coil for 
approximately 10 seconds in order to remove the outside coating.  The capillary was 
then removed from the coil and wiped gently with a Kimwipe™ to remove the burnt 
polyimide coating.  The capillary was then examined under a light microscope to ensure 
that all coating was removed from the window.  The exact length of the short, detector 
end of the capillary was measured to ± 1.0 mm.   
Capillary assembly was based on the Beckman protocol.  A place 6.5 cm from 
the window on the long, injector, end of the capillary was marked.  This mark was 
placed onto the end of the spindle of the cartridge assembly; the capillary was then 
secured with a small piece of rubber tubing, Figure 4.  The capillary was then carefully 
wound around the spindle three times.  The other end of the capillary was secured to the 
opposite side of the spindle with rubber tubing.  Both ends of the capillary were inserted 
into the cartridge assembly and the spindle placed into the cartridge.  The capillary 
window was then aligned with the aperture of the cartridge.  The capillary was then 
secured in place.  The cartridge was then examined under a microscope to ensure proper 
alignment of the capillary window with the cartridge aperture.  Rubber gaskets were 
placed around the capillary window and spindle assembly.  Small rubber gaskets were 
also placed around the ends of each capillary to prevent leakage of the capillary coolant.  
The top of the cartridge assembly was then secured. 
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Fig. 4. Representation of capillary spindle and capillary with window (not to scale) 
 
The ends of the capillary were measured and cut using the capillary template 
provided.  The length of each end cut was measured to ± 1.0 mm and subtracted from the 
total length of the capillary.  This value is referred to as the total length of the capillary, 
LT.  The length to detector, LD, was calculated by subtracting the length of the windowed 
detector end of the capillary measured above, less the length cut off, from the total 
capillary length.  The capillary was clearly labeled with LT and LD and these 
measurements were used to calculate effective mobilities (µe ) using the following 
equation: 
µe =LcLd (1/t-1/tEOF) 
        V 
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Ld 
  32   
where Lc is the total length of the capillary (cm), Ld is the length of the capillary from 
injector to detector (cm), V is the applied voltage (volts), t is the migration time of the 
sample (sec), and tEOF is the migration time of the EOF marker (sec).   
Ultrafiltration 
 Prior to analysis by CE samples were ultrafiltrated to remove any remaining 
saline or sucrose solution and concentrate the lipoproteins.  For analysis of intact 
particles samples were filtered in 2.5mM PBS.  Approximately 250µL of samples, fresh 
or previously frozen, were mixed with 250µl of 2.5 mM PBS.  Using a 100,000MW 
Micron filter (Millipore, Billerica, MA) samples were centrifuged for 8 min at 9000 rpm.  
This was repeated 3 times with addition of ~ 200µl of buffer prior to each spin.  Hen 
VLDL samples required additional filtration and were centrifuged twice more for 8 min 
at 9000 rpm without addition of buffer.  The filter was then inverted into a clean tube 
and then spun for 3 min at 6500 rpm to allow collection of all remaining sample.  Prior 
to analysis all samples were diluted 1:1 with 2.5mM PBS.   
Samples that were to be delipidated prior to CE analysis were ultrafiltrated using 
100,000 MW filter and centrifuged for 8 min at 9000rpm without the addition of buffer.  
Prepared samples were mixed 1:2 with SDS buffer, vortexed, and allowed to incubate 
for 45 min at 60°C.     
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Capillary Electrophoresis 
Capillary electrophoresis took place using Beckman P/ACE system, Model 5510, 
and photo-diode array detector.  The background electrolyte (BGE) for intact particles 
was phosphate buffer (PBS).  A stock solution of 38mM phosphate buffer was made 
which consisted of 30 mM Na2HPO4 and 8mM NaH2PO4.  This solution was further 
diluted to 5mM for CE analysis and 2.5mM for ultrafiltration.  The BGE used for 
delipidation of lipoproteins (SDS) contained 50mM sodium borate, 20% acetonitrile 
(v/v) and 3.5 mM SDS [48].  The electroosmotic flow marker (EOF) for all experiments 
was .001% DMSO.   Prior to each use the BGE was degassed using vacuum sonication 
until bubbles were no longer seen.   
The capillary was conditioned before being used and prior to each day’s use. A 
series of treatments are used to properly condition the capillary. The capillary was first 
rinsed for 5 min with 1.0 N NaOH.  This was followed by a 10 min rinse with 0.1 N 
NaOH and 10 min rinse with deionized H20.  Prior to injection of sample an EOF test 
was run to ensure adequate capillary conditioning.  The EOF test was conducted as 
follows: the capillary was first rinsed for two minutes with the appropriate BGE 
followed by a 5 sec injection of EOF.  Each end of the capillary was then placed in to a 
vial containing BGE and voltage applied across the capillary at 16kV.  If the EOF 
marker failed to appear after 6 min, for PBS, or 8 min, for SDS, the capillary was 
reconditioned prior to use.  Between each sample run the capillary was rinsed with 0.1 N 
NaOH for 1 min followed by 1 min rinse with deionized H20. 
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Approximately 100µl of sample was placed into the sample vial.  Prior to sample 
injection the capillary was rinsed with BGE for 2 min, followed by a 5 sec injection of 
EOF and finally a 5 sec injection of sample.  Each end of the capillary is then placed into 
vials containing BGE and voltage, 16kV, applied across the capillary.  Detection took 
place between 190 and 300nm.  Peak areas, migration times and µe were determined 
using the Beckman P/ACE system software. 
Statistics 
Mean, standard deviation and coefficient of variation of particle diameters for 
each lipoprotein class were determined using the median particle diameter calculated by 
system software for each individual sample.  Paired t-tests were used to determine 
significant differences between particle diameters of first step particles isolated from the 
livers of estrogen naïve and estrogen treated roosters.  Observed differences in effective 
mobility for lipoprotein classes were also analyzed using unpaired, unequal variance, t-
tests.  Differences were deemed statistically significant at p  .05. 
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CHAPTER V 
 
RESULTS 
 
Diameter Distribution Studies 
 Particle diameter distributions were measured for plasma VLDL and VLDLy.  
Median particle diameter for plasma VLDL from untreated roosters was 49.2 ± 23.2 nm.  
Median particle diameter for plasma VLDL was 17.6 ± 1.7 nm 12 hours after estrogen 
treatment and 16.8 ± .8 nm 24 hours after hormone exposure.  Median diameter for 
plasma VLDLy from hen was 19.0 ± 1.0 nm.  As predicted the particle diameter 
distribution for untreated rooster VLDL was much more variable than the distribution 
from either the laying hen or estrogen treated roosters.  Particle diameter for estrogen 
injected birds and hens were much more uniform.  These results are similar to those 
previously established within this laboratory [6].  Table 3 provides a summary of particle 
diameters for plasma VLDL and VLDLy.   
 
 
Table 3 
Particle diameter for plasma VLDL from estrogen naïve roosters, estrogen treated roosters and laying 
hens.  Particle diameters listed at both 12 and 24 hours after estrogen treatment for estrogen treated 
roosters.  Particle diameter as determined by dynamic laser light scattering. 
 
 
Median 
Diameter 
(nm) Std Dev 
Coefficient 
of Variation n= 
Rooster 49.2 23.2 .472 18 
Rooster +12 16.8 .8 .048 3 
Rooster +24 17.6 1.7 .101 7 
Hen 19.0 1.0 .053 11 
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Particle diameter distributions were also measured for first step particles.  The 
median particle diameter of first step particles from an untreated rooster was 31.5 ± 6.8 
nm.  The median particle diameter of first step particles decreased dramatically, to 16.1 
± 1.6 nm, 12 hours after estrogen injection.  Twenty-four hours after estrogen injection 
median particle diameter of first step particles increased to 23.9 ± 6.2 nm.  The increase 
in diameter of first step particles 24 hours after estrogen exposure likely reflects the end 
of estrogens effect on the liver.  This is consistent with previous studies which have 
shown that estrogen effectively induces translation of apo VLDL II for 24 hours, after 
which the effect wanes [5].  Table 4 provides a summary of the particle diameters of first 
step particles. 
 
 
 
Table 4 
Particle diameters for first step particles from estrogen naïve roosters and estrogen treated roosters (12 and 
24 hours after treatment).   Particle diameter as determined by dynamic laser light scattering. 
 
 
Median 
Diameter 
(nm) Std Dev 
Coefficient 
of Variation 
 
n= 
Rooster 31.5 6.8 .100 8 
Rooster +12 16.1 1.6 .066 3 
Rooster +24 23.9 6.2 .110 7 
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Isolation of VLDL Assembly Intermediates  
Figure 5 is an electron micrograph of a thin section of a cocadylate perfused 
hen’s liver.  As hen livers are fatty, large lipid droplets are visualized in the electron 
micrograph.  Nascent VLDLy particles, identified by open arrows, are visible within the 
juncture of the RER and SER.  The large amount of lipid present within the hepatocyte 
limits resolution of VLDLy located within the secretory compartments of the Golgi (G) 
are not visible in this image.  
Figure 6 depicts electron micrographs of plasma VLDL from immature birds and 
VLDLy from hens as well as VLDLy assembly intermediates isolated from hen liver.  
Note the dramatic reduction of particle size of serum VLDLy from the laying hen (top 
left), with particles ranging from 27.5-45 nm, compared to serum VLDL from estrogen 
naïve chicks (top right), 40-120 nm.  This is similar to the reduction in particle diameter 
observed using the dynamic laser light scattering technique.  First step particles isolated 
from RER of hen hepatocytes (lower right) ranged in size from 15-23 nm.  This was 
similar to the particle diameter for first step particles isolated from RER of estrogen 
treated roosters which had a median diameter of 16.1 nm, as determined by dynamic 
laser light scattering. 
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Fig. 5.  Electron micrograph of laying hen hepatocyte.  Open arrows point towards nascent VLDLy 
particles within the RER-SER membrane compartments.  Particle diameter of these particles was 27.5-
45nm.  Due to the high levels of lipid present within hen hepatocytes there was inadequate resolution of 
VLDLy particles within the secretory vesicles of the Golgi (G). 
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Fig. 6.  Electron micrograph (x180,000) of plasma VLDL and hepatocyte VLDL assembly intermediates.  
UPPER LEFT:  Laying hen plasma VLDLy (27.5-40nm).  MIDDLE LEFT:  VLDLy from Golgi of laying 
hen hepatocytes (27.5-40nm).  BOTTOM LEFT:  VLDLy from RER of laying hen hepatocytes (27.5-
45nm).  UPPER RIGHT:  Estrogen naïve chick plasma VLDL (40-120nm).  MIDDLE RIGHT:  Second 
step particles from RER of laying hen hepatocytes (22.5-27.5nm).  LOWER RIGHT:  First step particles 
from RER of laying hen hepatocytes (15-23nm). 
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Capillary Electrophoresis of Intact Particles 
Fresh VLDL particles were electrophoresed in untreated silica capillaries filled 
with 5mM PBS after being ultrafiltrated with 2.5 mM PBS using a 100,000MW Micron 
filter (Millipore, Billerica, MA).  When intact VLDLy from hen plasma was run, a single 
peak was detected with an average effective mobility (µe) of -14.7 x 10-5 cm2/V.s, Figure 
7.  Similar results were observed from VLDLy from estrogen treated roosters for which 
µe was -14.1  x 10-5 cm2/V.s.  
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 Fig. 7.  Electropherogram of hen VLDL. BGE: 5mM PBS.  UV absorbance at 200nm. 
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When intact VLDL from untreated roosters was run under the same conditions as 
the VLDLy, multiple peaks were observed when analyzed at 200nm, Figure 8.  The 
number of peaks detected varied from between two and four.  Effective mobilities 
ranged from -12.6 to -28.7 x 10-5 cm2/V.s.  See Table 5 for a summary of detected peaks.  
Assuming all particles are of similar charge due to the presence of apolipoproteins 
“subclasses” would represent particles of various molecular weights.  These likely 
represent VLDL which have undergone varying degrees of hydrolysis.  The particles 
eluting first, those with lower µe represent more newly produced VLDL.  The peaks with 
larger µe would be particles of smaller size or partially hydrolyzed VLDL.  
 
 
 
Table 5 
Electrophoretic mobilities of plasma VLDL from 3 untreated roosters. 
 
 
Mobility (X10-5 cm2/V.s) 
 Peak 1 Peak 2 Peak 3 Peak4 
 
 
Fresh 
  
Rooster 1 -14.9 -19.9 -21.7  
Rooster 2 -12.6 -18.4 -23.8  
Rooster 3 -12.8 -19.8 -24.0 -28.7 
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Fig. 8.   Electropherogram of fresh rooster VLDL.  BGE: 5mM PBS.  UV absorbance at 200nm. 
 
First step particles from estrogen naïve and estrogen treated birds, both 12 and 24 
hours after treatment, were collected.  First step particles were cryopreserved as 
described in Chapter IV.  They were than ultrafiltrated and electrophoresed in the same 
manner as the intact VLDL and VLDLy.  For all first step particles a single peak was 
detected when analyzed at 200nm, Figures 9 and 10.  Average µe for first step particles 
from estrogen naïve rooster was -25.4 x10-5 cm2/V* ± 0.38.  Average mobility for first 
step particles from estrogen injected roosters was -23.0 ± 0.10 and -23.3 x10-5 ± 0.17 
cm2/V.s at 12 hours and 24 hours, respectively. This difference was significant at both 
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time points, p<.02.  The peak areas from estrogen treated birds were significantly greater 
than those from the untreated roosters and the peaks much more well defined.  Table 6 
provides a summary of mobilities and areas for intact first step particles. 
 
 
Table 6 
Average area and electrophoretic mobility of first step particles from estrogen naïve roosters and estrogen 
treated roosters (12 and 24 hours after estrogen treatment).  Standard deviation (SD) and coefficient of 
variation of mobilities at each time point.  UV absorbance measured at 200 nm. 
 
 
Average 
Area 
Average 
Mobility 
(X10-5 
cm2/V.s) SD (Mobility) 
Coefficient 
of Variation 
(Mobility) 
Control 173806 -25.4 0.38 .015 
12 hour 482858 -23 0.10 .004 
24 hour 547800 -23.3 0.17 .007 
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Fig. 9.  Electropherogram of first step particles from an estrogen naïve rooster.  BGE: 5mM PBS.  UV 
absorbance at 200 nm. 
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Fig. 10.  Electropherogram of first step particles from an estrogen treated rooster (24 hours after estrogen 
treatment).  BGE: 5mM PBS.  UV absorbance at 200 nm. 
 
 
 
Cryopreservation Studies 
 
A desire for greater flexibility in experimental design prompted storage stability 
studies with circulating plasma lipoproteins.  In these experiments the performance of 
freshly isolated material was compared to that of those same materials after 
cryopreservation as specified in Chapter IV.  Intact fresh and previously frozen rooster 
VLDL and hen VLDLy were first ultrafiltrated and then electrophoresed in an untreated 
silica capillary filled with 5 mM PBS. 
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Freezing did not significantly affect the mobility of the intact VLDLy particles.  
A single peak was detected for fresh VLDLy particles with an average µe of -14.7 x 10-5 
cm2/V.s.  A single peak was also detected from the frozen VLDLy particles.  Average µe 
of previously frozen particles was -14.3 x 10-5 cm2/V.s.  The observed difference in 
mobility between fresh and frozen hen VLDLy of 0.4 x10-5 cm2/V.s was not statistically 
significant, p=0.2.  
The effects of freezing were significant in rooster VLDL.  The distinct subclasses 
detected in the fresh samples were not as clearly defined in the frozen samples.  Overall, 
mobility of the previously frozen particles increased.  Average mobility for all peaks in 
the fresh sample was -19.3 x10-5 cm2/V.s, average mobility for all peaks from the frozen 
samples was -25.8 x10-5 cm2/V.s.  This difference was deemed statistically significant 
with p<.01.  See figure 11 and table 7 for comparisons of fresh and frozen rooster 
VLDL. 
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Fig. 11.  Electropherograms of fresh and frozen rooster VLDL.  BGE: 5mM PBS.  UV absorbance at 
200nm.   
 
 
 
Table 7 
Electrophoretic mobilities of fresh and frozen plasma VLDL from 3 estrogen naïve roosters. 
 
 
Mobility (X10-5 cm2/V*s) 
 Peak 1 Peak 2 Peak 3 Peak4 
 
 
Fresh 
  
Rooster 1 -14.9 -19.9 -21.7  
Rooster 2 -12.6 -18.4 -23.8  
Rooster 3 -12.8 -19.8 -24.0 -28.7 
 
 
Frozen 
  
Rooster 1 
  -25.0 -29.4 
Rooster 2 
  -23.6 -27.7 
Rooster 3 
  -20.1 -27.5 
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Capillary Electrophoresis of Delipidated Particles 
 Electropherograms from delipidated particles were analyzed at 214 nm.  Multiple 
peaks were visible for all samples at this wavelength.  At 214 nm both protein and lipid 
components will be detected.  Electropherograms for delipidated samples were also 
analyzed at 280 nm in order to observe only the protein components of the sample.  Any 
peaks visible at both 214 nm and 280 nm were assumed to be valid protein components 
of the particle.   
Methods for delipidation of VLDL and first step particles were adapted from 
methods routinely used within the Macfarlane laboratory [48].  Human lipoprotein 
samples have been successfully delipidated with an incubation temperature of 37 °C.  
We did attempt to delipidate hen VLDLy at 37°C unsuccessfully, see Figure 12.  
Inadequate delipidation was achieved at that temperature.  This was determined by 
analyzing the sample at both 214 and 280 nm.  A large “lipid” peak was observed with 
an approximate mobility of -29 x 10-5 cm2/V.s.  Previous studies, using a similar CE 
buffer system, have established µe for human apo B at approximately -19 x 10-5 cm2/V.s.  
A peak with similar µe, -20 x 10-5 cm2/V.s, was observed in this sample. However, there 
was a large peak between presumed apo B peak and the “lipids” peak representing 
inadequately delipidated particles.   
The inadequate delipidation was attributed to the facts that birds have a higher 
body temperature, 41°C, as compared to humans with a body temperature of 37°C.  
Delipidation of hen VLDLy was more successful after incubation with SDS buffer for 45 
min at 60°C, Figure 13. These particles were analyzed by CE and multiple peaks were 
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observed when analyzed at 214 nm.  One large peak was observed with a mobility of 
approximately -24x10-5 cm2/V.s.  When analyzed at 280 nm this peak was resolved into 
several smaller peaks.  At 214 nm a large peak was also visible with a mobility of 
approximately -29x10-5 cm2/V.s.  This peak was not visible at 280 nm and was assumed 
to be the lipid component of the VLDL.  There were several peaks with mobilities 
ranging from -20 to -26 x 10-5 cm2/V.s.  This indicated that there were likely some 
inadequately delipidated apo B containing particles remaining.  Table 8 provides a 
summary of peaks observed at 280 nm from delipidated VLDLy of 4 different hens. 
 
 
 
Table 8 
Electrophoretic mobilities of separated proteins from plasma VLDLy of 4 hens. 
 
Mobility (X10-5 cm2/V.s) 
 
Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 Peak 6 Peak 7 
Hen 1 -1.60 -9.68 -20.11 -22.83 -23.04 -24.69  
Hen 2 -1.64 -9.47 -20.10 -22.13 23.0 -24.69  
Hen 3 -2.25 -9.61 -20.51 -21.24 -22.74 -23.55  
Hen 4 -2.27 -8.94 -19.76 -22.06 -22.82 -25.40 -26.34 
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Fig. 12.  Electropherogram of inadequately delipidated hen VLDLy.  Sample was incubated 45 min at 
37°C, 1:2 ratio (sample:SDS).  BGE: 3.5 mM SDS.  UV absorbance at 214nm. 
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Fig. 13. Electropherogram of delipidated hen VLDLy.  Sample was incubated for 45 min at 60°C, 1:2 
(sample:SDS).  Large “lipids” peak visible at 214 nm.  BGE: 3.5mM SDS Buffer.  UV absorbance at 214 
nm. 
 
 
VLDL from untreated roosters was delipidated in the same manner.  Again, 
multiple peaks were visible at 214 nm, Figure 14.  These peaks had similar mobilities to 
those observed in the hen.  No peak was observed in the region of the lipids observed in 
then hen VLDL.  Multiple peaks were observable at 280 nm as well.  A summary of 
visible peaks at 280nm for delipidated rooster VLDL can be found in table 9.  One peak 
was noticeably absent from the rooster VLDL in comparison to Hen VLDL.  The peak 
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identified as Peak 2 in Table 8 with a mobility of approximately -9.6x10-5 cm2/V.s, was 
not detected in any of the untreated rooster samples. 
 
 
Table 9 
Electrophoretic mobilities of separated proteins from plasma VLDL of 3 estrogen naïve roosters. 
 
Mobility (X10-5 cm2/V*s) 
 
Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 Peak 6 Peak 7 
Rooster 1 -2.22 -21.86 -22.31    -26.19 
Rooster 2 -1.86 -19.88 -22.96 -23.82 -24.25 -24.88  
Rooster 3 -1.97 -20.00  -24.26 -24.67 -25.02 -26.02 
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Fig. 14.  Electropherogram of plasma VLDL from an estrogen naïve rooster.  BGE: 3.5mM PBS. UV 
absorbance at 214 nm. 
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VLDL from estrogen treated roosters, 24 hours post estrogen injection, was also 
delipidated using SDS.  Electropherograms for these samples were analyzed at both 214, 
Figure 15, and 280 nm, Figure 16.  These electropherograms resembled those from the 
hen.  A “lipid” peak was detectable at 214 nm, which was not observed when analyzed 
at 280 nm.  An additional peak was observed with a mobility of approximately -10.5x10-
5 cm2/V.s, which was not observed in the untreated rooster samples.  Table 10 provides a 
summary of peaks detected at 280 nm in VLDL from estrogen treated roosters.  
 
 
Table 10 
Electrophoretic mobilities for separated proteins from plasma VLDLy of 3 estrogen treated roosters (24 
hours after estrogen treatment). 
 
Mobility (X10-5 cm2/V*s) 
 
Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 Peak 6 Peak 7  
Rooster 1 -1.54 -10.58 -19.59 -20.39 -22.10 -23.64 -25.61  
Rooster 2 -1.63 -10.49 -19.11 -20.11 -21.79 -23.72 -25.62  
Rooster 3 -1.77 -10.45 -19.42 -20.70 -21.70 -21.70 -25.99  
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Fig. 15.  Electropherogram of plasma VLDLy from an estrogen treated rooster, UV absorbance at 214 nm 
(24 hours after estrogen treatment).  BGE: 3.5mM SDS.  UV absorbance at 214 nm. 
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Fig. 16.  Electropherogram of plasma VLDLy from an estrogen treated rooster,  UV absorbance at 280 nm 
(24 hours after estrogen treatment).  BGE: 3.5mM SDS.   
 
 
First step particles from both control and estrogen treated rooster were 
delipidated by incubation at 60°C for 45 min in 3.5mM SDS.  After incubation with SDS 
particles were separated with CE and analyzed at both 214 and 280 nm.  Multiple peaks 
were observable at 214 nm for both control, Figure 17, and estrogen treated, Figure 18, 
first step particles.  A small “lipid” peak was visible at 214 nm.  
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When analyzed at 280 nm only two peaks were visible for first step particles 
from control birds.  Delipidated first step particles from estrogen treated birds had 
multiple observable peaks when analyzed at 280 nm.  A summary of peaks observed at 
280 nm for first step particles from control and estrogen treated birds are found in Tables 
11 and 12. 
 
 
 
 
Table 11 
Electrophoretic mobilities for separated proteins from delipidated first step particles from three estrogen 
naïve roosters. 
 
Mobility (X10-5 cm2/V*s) 
 
Peak 1 Peak 2 
Rooster 1 -19.83 -21.06 
Rooster 2 -19.94 -20.91 
Rooster 3 
 -21.20 
 
 
 
 
 
 
 
 
Table 12 
Electrophoretic mobilities for separated proteins from delipidated first step particles from four estrogen 
treated roosters (24 hours after estrogen treatment). 
 
Mobility (X10-5 cm2/V*s) 
 
Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 Peak 6 
Rooster+ 1 -4.85 -10.56 -21.12 -24.63 -25.56 -26.41 
Rooster+ 2 -5.61 -9.84 -20.11  -26.93  
Rooster+ 3 -5.93 -10.90 -22.02 -23.25 -25.28 -26.52 
Rooster+ 4 -5.60  -21.85 -23.72 -24.63 -27.96 
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Fig. 17.  Electropherogram of first step particles from an estrogen naïve rooster.  BGE: 3.5mM SDS.  UV 
absorbance at 214 nm. 
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Fig. 18.  Electropherogram of first step particles from an estrogen treated rooster (24 hours after estrogen 
treatment).  BGE: 3.5mM SDS.  UV absorbance at 214 nm. 
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CHAPTER VI 
 
DISCUSSION 
 
 
 The chicken is an excellent model for studying triglyceride-rich lipoprotein 
assembly in liver due to the ability of injected estrogen to rapidly increase VLDL 
production.  The affects of estrogen on plasma lipoproteins has been well studied, but 
relatively little is known about the intermediate forms of these particles. This study has 
demonstrated successful isolation of VLDL assembly intermediates from chicken liver.  
The concentration of first step VLDL particles found in the RER of rooster livers 
increased dramatically in response to exogenous estrogen injection. This was 
demonstrated by comparing the area under the curve values obtained from 
electropherograms of first step particles from untreated and estrogen treated roosters.   
 Estrogen not only increased the number of first step particles but it also altered 
the diameter of the first step particles.  This study demonstrated that first step particles 
from estrogen treated birds have significantly smaller diameters than those isolated from 
the livers of estrogen naïve roosters.  The diameter of first step particles increases 24 
hours after estrogen treatment.  This is consistent with previous studies which have 
shown that estrogen’s effects on the liver decline 24 hours after exposure [5]. 
 The present studies suggest that CE is an effective method for the study of intact 
VLDL and first step VLDL particles.  Determination of charge:volume is a unique 
physical characteristic which has not been well studied in these particles.  This study 
demonstrated that effective mobilities for plasma VLDLy from hens and estrogen treated 
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roosters, µe  -14 x 10-5 cm2/V.s, was lower than the average effective mobility for 
plasma VLDL from estrogen naïve roosters in which average µe for all subclasses was  
-25.4 x 10-5 cm2/V.s.  This difference in mobility indicates that rooster VLDL has a 
larger charge:volume than VLDLy.  This is consistent with our hypothesis as the 
presence of a relatively positively charged apolipoprotein, apo VLDL II, would be 
expected to decrease µ e. 
 This study also demonstrated the presence of possible “subclasses” within rooster 
plasma VLDL.  A wide distribution of particle diameters would be expected in rooster 
VLDL as it is susceptible to lipoprotein lipase.  Hydrolysis of the VLDL would lead to 
lipoproteins of various diameters.  Charge would remain relatively constant due to the 
presence of apo B and other apolipoproteins.  The neutral lipids lost due to hydrolysis 
would lead to decreased mass of the particle but would not affect the net charge.  
Therefore, the charge:volume of the VLDL particle would increase as a result of 
hydrolysis.  If indeed these “subclasses” represent VLDL at varying degrees of 
hydrolysis than the peaks furthest to the left, those with the lowest µe, would represent 
newly produced VLDL particles.  Those peaks with higher µ e represent older, more 
hydrolyzed VLDL.  In previous studies of lipoprotein particle diameters our laboratory 
has shown that particle diameter of VLDL from untreated roosters is widely variable.  
However, we have never observed such distinct “subclasses” as were observed when 
these particles were separated using CE.  VLDLy is not susceptible to hydrolysis by 
lipoprotein lipase and “subclasses” were not observed in plasma VLDLy from hens or 
estrogen treated roosters. 
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 Intact first step VLDL assembly intermediates isolated from rooster liver were 
also analyzed using CE.  First step particles from estrogen treated roosters had lower µe 
than those from estrogen naïve roosters.  This difference was significant at both 12 and 
24 hours after estrogen treatment.  This decrease in µe represents decreased 
charge:volume.  Based on the particle diameter studies we know that first step particles 
from estrogen treated roosters have smaller particle diameters than those from estrogen 
naïve birds.  If decreased diameter were the only change to occur in response to estrogen 
than we would expect an increase in charge:volume and therefore higher µe.  The 
opposite effect was observed in these studies, suggesting that some other change, other 
than decreased particle diameter, occurs in these particles.  The presence of a positively 
charged protein, such as apo VLDL II, in conjunction with decreased particle diameter 
could explain this decrease in µe.  The calculated area under the curve for first step 
particles increased significantly after estrogen exposure.  This is consistent with the 
known increase in VLDL production that occurs in response to estrogen. 
It is important to note that these studies were done with previously frozen first 
step particles. If cryopreservation affects charge:volume equally for first step particles 
from both estrogen naïve and estrogen treated roosters than these differences would still 
be apparent.  However, the effects of cryopreservation with sucrose are unknown for 
first step particles.  As cryopreservation did affect the electrophoretic mobility of some 
of the particles examined in these studies, the affects of the freeze/thaw process on first 
particles will need to be further evaluated.  
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The effects of freezing are only problematic when looking at intact particles.  
The presence of SDS used to delipidate the lipoproteins would eliminate any aggregation 
that had occurred during the freeze/thaw process. In this study charge:volume of intact 
rooster VLDL was altered by cryopreservation even with the addition of sucrose.  
Average effective mobility of previously frozen, intact rooster VLDL was greater than 
that of fresh samples.  This effect was not significant in hen VLDLy.  It is possible that 
some physical chemical property of VLDLy make it less susceptible to the effects of 
freezing.  It may be that the smaller diameter of VLDLy is cryoprotective.  The hen 
VLDLy in this study had an average diameter of ~20nm, similar to that of the human 
LDL used in Rumsey’s cryopreservation study.  Their study demonstrated successful 
cryopreservation of human LDL by the addition of sucrose [43].  This method of 
cryopreservation has not previously been tested on VLDL particles.  Our study suggests 
that the addition of sucrose may not be protective for all types of lipoproteins during the 
freeze thaw process.  The level of protection provided may be dictated by the diameter 
of the lipoprotein particles.  The effects of cryopreservation with sucrose were not 
evaluated for first step particles.  If indeed size is a factor than the smaller first step 
particles may be protected by the addition of sucrose. 
 This study also demonstrates the potential use for CE in the further elucidation of 
the proteins involved in the VLDL assembly process.  The presence of apo B on the first 
step particle is key to the process of VLDL assembly.  It is unknown whether or not first 
step particles also contain other apolipoproteins.  Previous studies within our 
collaborators’ laboratory demonstrated that human apo B-100 has an effective mobility 
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of approximately -19 x 10-5 cm2/V.s when a similar SDS-containing CE buffer was used 
[48].  As the amino acid sequence of apo B is highly conserved across species [15] it 
seemed likely that chicken apo B would demonstrate similar mobility.  Delipidated 
plasma VLDL and VLDLy showed a peak with approximate mobility of -20 x10-5 
cm2/V.s.  As this peak appeared consistently throughout all plasma VLDL, VLDLy and 
first step particles and has a similar mobility to those previously observed, it may 
represent apo B.   
 In most samples multiple peaks with larger effective mobilities, ranging from -21 
to -26 x10-5 cm2/V.s, were observed.  These likely represent particles that contain apo B 
but have retained some of the lipid components.  Such an outcome would be consistent 
with previous studies in which VLDL from hyperlipidemic humans demonstrated a 
similar profile when separated using the same buffer system [48].  
 In the presence of SDS all proteins have the same charge:volume ratio as SDS 
binds to proteins in a specific ratio.  This means that separation of proteins is entirely 
based on molecular weight.  A small peak with an effective mobility of approximately -2 
x 10-5 cm2/V.s was detected in all of the plasma VLDL and VLDLy sample.  It is likely 
that this peak represents one of the smaller apolipoproteins such as apo C-I with an 
approximate MW of 6.6 kDa. 
A unique peak was present exclusively in delipidated plasma VLDLy from hens 
and estrogen treated roosters.  This peak had a mobility of approximately -10 x 10-5 
cm2/V.s.  This peak may represent apo VLDL II as it is seen only in those birds exposed 
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to estrogen.  This peak had a lower effective mobility than apo B and therefore 
represents a protein of lower molecular weight.   
A peak with similar mobility, to that of the presumed apo VLDL II peak, was 
also observed in the delipidated first step particles from estrogen treated roosters.  This, 
along with the shift in mobility of intact first step particles discussed above, would 
further support the presence of apo VLDL II on the first step particles of estrogen treated 
roosters.  A second peak with an effective mobility of approximately -5 x 10-5 cm2/V.s 
was detected for first step particles from estrogen treated birds.  This peak was not 
detected on any of the other samples.  This peak has a mobility half that of the presumed 
apo VLDL II peak.  In chickens apo VLDL II functions as a homodimer.  It may be that 
this peak represents the monomeric form of apo VLDL II.  Apo VLDL II is responsible 
for the decreased particle diameter of VLDLy, its presence on the first step particle 
would suggest that the diameter of the mature VLDLy may be determined during the 
first step of VLDL assembly.   
 In order to positively identify these protein components, application of additional 
analytical techniques would be required. One possibility would be to obtain known 
protein standards and determine effective mobilities of those standards using this CE 
buffer system.  Another option would be to combine the use of CE with mass 
spectrometry, allowing more accurate identification of each of the protein components.     
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CHAPTER VII 
 
SUMMARY AND CONCLUSIONS 
 
 This project was able to demonstrate successful isolation of first step VLDL 
assembly intermediates from hen and rooster liver.  CE was shown to be a useful method 
for the study of intact VLDL, VLDLy and first step VLDL particles.  Cryopreservation 
with sucrose significantly altered the charge:volume of intact rooster VLDL.  This study 
suggests that CE may be useful in the study of VLDL subclasses.  CE can also be used to 
separate individual protein components from delipidated VLDL, VLDLy and first step 
VLDL particles.  Use of this method, in conjunction with mass spectrometry, may lead 
to the identification of those proteins found on the first step particle.  Increasing our 
knowledge of VLDL assembly intermediates gives us further insight into the VLDL 
assembly process. 
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